Dr. Jonathan H. Mckinnon, M.D.
Neurology (Neurology Physician)
7575 W Washington Ave, Suite 127-160
Las Vegas, NV 89128
Who else practices at this address →
Clark County includes primary care (9% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Ohio State University College of Medicine (2005)
- Years since graduation
- 21
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 276
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2005Medical school: Ohio State University College of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
NV license 14137 · AZ license 36035 -
Neuromuscular Medicine (Psychiatry & Neurology) Physician
NV license 14137
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Billings Clinic Hospital Billings, MT
- Bozeman Health Deaconess Hospital Bozeman, MT
- Bozeman Health Big Sky Medical Center Big Sky, MT
- Madison Valley Medical Center Ennis, MT
- Ruby Valley Medical Center Sheridan, MT
Medical groups
- Big Sky Medical Associates PLLC (2 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 276
- Services billed
- 2,993
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Injection, onabotulinumtoxina, 1 unit | 4,205 | 20 |
| Needle measurement of electrical activity in arm or leg muscles, complete study | 467 | 139 |
| Established patient office or other outpatient visit, 30-39 minutes | 431 | 256 |
| Nerve conduction, 13 or more studies | 234 | 139 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 107 | 11 |
| Established patient office or other outpatient visit, 40-54 minutes | 82 | 59 |
| New patient office or other outpatient visit, 60-74 minutes | 60 | 60 |
| New patient office or other outpatient visit, 45-59 minutes | 44 | 44 |
| Testing of nerve-muscle junction | 29 | 15 |
| Measurement of brain wave activity (eeg), 41-60 minutes | 26 | 26 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Gabapentin Other prescribers in Las Vegas, NV | 91 |
| Prednisone Other prescribers in Las Vegas, NV | 84 |
| Donepezil Hcl Other prescribers in Las Vegas, NV | 83 |
| Gamunex-C (immune globul g/gly/iga avg 46) | 80 |
| Gammaplex (immun glob g(igg)/gly/iga 0-50) | 64 |
| Levetiracetam Other prescribers in Las Vegas, NV | 64 |
| Carbidopa-Levodopa (carbidopa/levodopa) Other prescribers in Las Vegas, NV | 63 |
| Privigen (immun glob g(igg)/pro/iga 0-50) | 62 |
| Ondansetron Odt (ondansetron) Other prescribers in Las Vegas, NV | 47 |
| Radicava Ors (edaravone) | 45 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 4 companies reported 10 payments worth $207 in total to this clinician.
| AbbVie Inc. | $76.65 |
|---|---|
| Celgene Corporation | $60.09 |
| Ipsen Biopharmaceuticals, Inc | $55.31 |
| Biogen, Inc. | $14.83 |
| Food and Beverage | $207 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 3 companies. The companies reported $107,304 in research payments for these studies, mostly to the institutions running them.
- Study name not reported
Sarepta Therapeutics, Inc. - A Phase 3, Randomized, Double blind, Placebo controlled, Parallel, Multicenter Study to Evaluate the Safety and Efficacy of ALXN1720 in Adults with Generalized Myasthenia Gravis
Alexion Pharmaceuticals, Inc. - Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis
UCB SA · Completed · NCT04225871
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.